[go: up one dir, main page]

CN116808007A - A method for producing a light wave reflection blood vessel developing skin surface disinfectant - Google Patents

A method for producing a light wave reflection blood vessel developing skin surface disinfectant Download PDF

Info

Publication number
CN116808007A
CN116808007A CN202111483326.0A CN202111483326A CN116808007A CN 116808007 A CN116808007 A CN 116808007A CN 202111483326 A CN202111483326 A CN 202111483326A CN 116808007 A CN116808007 A CN 116808007A
Authority
CN
China
Prior art keywords
skin surface
blood vessel
light wave
disinfectant
wave reflection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111483326.0A
Other languages
Chinese (zh)
Inventor
张志平
张凯尧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Linyi Kaixing Medical Technology Co ltd
Original Assignee
Linyi Kaixing Medical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Linyi Kaixing Medical Technology Co ltd filed Critical Linyi Kaixing Medical Technology Co ltd
Priority to CN202111483326.0A priority Critical patent/CN116808007A/en
Publication of CN116808007A publication Critical patent/CN116808007A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052Small organic molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/006Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Communicable Diseases (AREA)
  • Optics & Photonics (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

本发明公开了一种光波反射血管显影皮肤表面消毒液的制作方法,所述消毒液由母液、消毒酒精和蒸馏水三者按一定的比例配合而成。通过把这种显影消毒液涂抹到待扎针部位的皮肤表面进行杀菌消毒的同时增强提高皮下血管的反光强度,使医护人员能够更加看清静脉血管,实施准确扎针,降低误扎率,起到皮肤消毒与血管显影的双重协同作用,降低扎针难度,提高医疗效率。The invention discloses a method for making a disinfectant solution for light wave reflection blood vessel development skin surface. The disinfectant solution is composed of mother liquor, disinfectant alcohol and distilled water in a certain proportion. By applying this developing disinfectant to the skin surface of the area to be acupuncture to perform sterilization and disinfection, it also enhances the reflective intensity of subcutaneous blood vessels, allowing medical staff to see the veins more clearly, perform accurate acupuncture, reduce the rate of mistaken acupuncture, and play a positive role in the skin. The dual synergistic effect of disinfection and vascular imaging reduces the difficulty of acupuncture and improves medical efficiency.

Description

一种光波反射血管显影皮肤表面消毒液的制作方法A method for producing a light wave reflection blood vessel developing skin surface disinfectant

技术领域Technical field

本发明涉及皮肤消毒与血管显影两个学科的医疗产品 交叉应用设计制造技术领域,特别是指一种光波反射血管显 影皮肤表面消毒液及其制作方法。The present invention relates to the technical field of cross-application design and manufacturing of medical products in the two disciplines of skin disinfection and blood vessel development, and in particular, to a light wave reflection blood vessel development skin surface disinfectant and a production method thereof.

背景技术Background technique

在医院里,打吊瓶输液时现在普遍采用的皮肤表面消毒液 是碘伏或75%医用酒精,用棉签蘸取后在需要扎针的部位对皮 肤表面进行擦拭消毒,在这里,皮肤消毒液的作用是单一的, 只能起到皮肤表面杀菌消毒作用,对皮下待扎针部位的静脉血 管起不到帮助识别便于准确下针的作用,所以,当遇到婴儿、 手背肥胖者或血管不便寻找的患者时,经常会出现数次扎针的 情况,给患者带来痛苦和给护士带来巨大的精神压力,造成医 患矛盾;现有的红外血管显影仪虽然可以起到帮助寻找皮下血 管的作用,但价格昂贵,体积较大,操作不便,所以虽然已经 出现多年但难以普及推广应用,这些矛盾有待解决。In hospitals, the commonly used skin surface disinfectant when injecting infusions is iodophor or 75% medical alcohol. Dip it with a cotton swab and wipe and disinfect the skin surface at the site where the needle needs to be inserted. Here, the skin disinfectant is It has a single function and can only sterilize and disinfect the surface of the skin. It cannot help identify the veins and blood vessels at the subcutaneous needle site to facilitate accurate needle placement. Therefore, when encountering infants, people with fat backs of hands, or people with difficulty finding blood vessels, Patients often need to be injected with needles several times, which brings pain to the patient and huge mental pressure to the nurse, resulting in conflicts between doctors and patients. Although the existing infrared vascular imaging device can help find subcutaneous blood vessels, However, it is expensive, large in size, and inconvenient to operate. Therefore, although it has been around for many years, it is difficult to popularize and apply it. These contradictions need to be resolved.

发明内容Contents of the invention

为了解决上述问题,本发明人进行了锐意研究,提供了一 种光波反射血管显影皮肤表面消毒液的制作方法,本发明利用 动物皮下静脉血管对蓝色光线98%的强反射特性,对比皮肤对 蓝色光线低于30%反射率的颜色反差原理,设计制造出一种光 波反射血管显影皮肤表面消毒液,把这种显影消毒液涂抹到待 扎针部位的皮肤表面进行杀菌消毒的同时增强提高皮下静脉血 管的反光强度,使医护人员能够更加看清静脉血管,实施准确 扎针,降低误扎率,起到皮肤消毒与血管显影的双重协同作用, 降低扎针难度,提高医疗效率。从而完成了本发明。In order to solve the above problems, the inventor conducted intensive research and provided a method for making a light wave reflection blood vessel developing skin surface disinfectant. The present invention utilizes the strong reflection characteristics of 98% of blue light by animal subcutaneous veins, and compares the skin's Based on the color contrast principle of blue light with a reflectivity lower than 30%, a light wave reflecting blood vessel developing skin surface disinfectant is designed and manufactured. This developing disinfectant is applied to the skin surface of the area to be acupuncture for sterilization and disinfection while enhancing subcutaneous improvement. The reflective intensity of veins enables medical staff to see veins more clearly, perform accurate acupuncture, and reduce the rate of mistaken acupuncture. It plays a dual synergistic role in skin disinfection and blood vessel visualization, reduces the difficulty of acupuncture, and improves medical efficiency. Thus, the present invention was completed.

本发明通过以下技术手段达到上述目的,一种光波反射血 管显影皮肤表面消毒液,其中消毒液由母液、消毒酒精和蒸馏 水三者按一定的比例配合而成。The present invention achieves the above object through the following technical means: a light wave reflection blood vessel developing skin surface disinfectant, wherein the disinfectant is composed of mother liquor, disinfecting alcohol and distilled water in a certain proportion.

进一步的,所述母液由蒸馏水、反射剂、反射增强剂、渗 透剂、光透明剂、非离子表面活性剂所组成。Further, the mother liquor is composed of distilled water, reflective agent, reflection enhancer, penetrating agent, optical transparency agent, and nonionic surfactant.

进一步的,所述反射剂采用型号JH501水溶性纳米级别无 毒环保冰晶蓝颜料和/或JH101嫩叶绿色颜料。Further, the reflective agent adopts model JH501 water-soluble nano-level non-toxic and environmentally friendly ice crystal blue pigment and/or JH101 young leaf green pigment.

进一步的,所述反射增强剂采用型号L6829水溶性无毒环 保蓝色纳米荧光颜料和/或L6828绿色纳米荧光颜料。Further, the reflection enhancer uses model L6829 water-soluble non-toxic environmentally friendly blue nano-fluorescent pigment and/or L6828 green nano-fluorescent pigment.

进一步的,所述渗透剂采用水溶性渗透剂。Further, the penetrant is a water-soluble penetrant.

进一步的,所述光透明剂采用水溶性聚乙二醇400和/或丙 三醇和/或葡萄糖。Further, the optical transparency agent uses water-soluble polyethylene glycol 400 and/or glycerol and/or glucose.

进一步的,所述非离子表面活性剂采用水溶性异丙醇酰胺 df21和/或十二烷基苯磺酸钠和/或聚氧乙烯醚系列的非离子型 表面活性剂。Further, the nonionic surfactant uses water-soluble isopropyl alcohol amide df21 and/or sodium dodecyl benzene sulfonate and/or polyoxyethylene ether series nonionic surfactants.

进一步的,所述蒸馏水采用常规蒸发过滤制取得的蒸馏 水,纯净程度要求符合国家相关标准,杂质含量不超过0.01%。Furthermore, the distilled water obtained by conventional evaporation and filtration must have a purity level that meets relevant national standards and an impurity content of no more than 0.01%.

进一步的,所述消毒酒精采用符合国家消毒制剂要求的工 业级医用消毒酒精,酒精纯度99.98%。Further, the disinfecting alcohol adopts industrial grade medical disinfecting alcohol that meets the national disinfection preparation requirements, and the alcohol purity is 99.98%.

通过本发明的一种光波反射血管显影皮肤表面消毒液的制 作方法,可以达到以下技术效果:Through the production method of a light wave reflection blood vessel developing skin surface disinfectant of the present invention, the following technical effects can be achieved:

本发明利用动物皮下静脉血管对蓝色光线98%的强反射特 性,对比皮肤低于30%反射率的颜色反差原理,,设计制造出 一种光波反射血管显影皮肤表面消毒液,把这种显影消毒液涂 抹到待扎针部位的皮肤表面进行杀菌消毒的同时增强提高皮下 血管的反光强度,使医护人员能够更加看清静脉血管,实施准 确扎针,降低误扎率,起到皮肤消毒与血管显影的双重协同作 用,降低扎针难度,提高医疗效率,具有积极的社会效益。This invention utilizes the strong reflection characteristics of 98% of blue light by animal subcutaneous veins, and the color contrast principle of skin with a reflectivity of less than 30%, to design and produce a light wave reflection blood vessel developing skin surface disinfectant, which develops this The disinfectant is applied to the skin surface of the area to be acupuncture for sterilization and disinfection. It also enhances the reflective intensity of subcutaneous blood vessels, allowing medical staff to see the veins more clearly, perform accurate acupuncture, reduce the rate of mispuncture, and play a role in skin disinfection and blood vessel visualization. The dual synergy reduces the difficulty of acupuncture, improves medical efficiency, and has positive social benefits.

附图说明Description of the drawings

图1是在手背涂抹常规75%消毒液的效果图Figure 1 is the effect of applying conventional 75% disinfectant on the back of the hand.

图2是在手背涂抹本发明产品后的血管显影效果图Figure 2 is a diagram of the blood vessel development effect after applying the product of the present invention on the back of the hand.

图3是在脚背涂抹手背涂抹常规75%消毒液后的效果图Figure 3 is the effect of applying conventional 75% disinfectant on the instep and the back of the hand.

图4是在脚背涂抹本发明产品后的血管显影效果图Figure 4 is a diagram of the blood vessel development effect after applying the product of the present invention on the instep.

具体实施方式Detailed ways

一种光波反射血管显影皮肤表面消毒液,由蒸馏水、 酒精、反射剂、反射增强剂、渗透剂、光透明剂、非离子表 面活性剂所组成,先用蒸馏水、反射剂、反射增强剂、渗透 剂、光透明剂、非离子表面活性剂,按照工艺要求制作成显 影母液,再把所述的母液与消毒酒精、蒸馏水按一定的比例 加入混合后制作出光波反射血管显影皮肤表面消毒液。A light wave reflection blood vessel developing skin surface disinfectant, which is composed of distilled water, alcohol, reflective agent, reflection enhancer, penetrant, optical transparency agent, and non-ionic surfactant. Agent, optical transparency agent, and non-ionic surfactant are prepared into a developing mother liquor according to the process requirements, and then the mother liquor, disinfecting alcohol, and distilled water are added and mixed in a certain proportion to produce a light wave reflective blood vessel developing skin surface disinfectant.

进一步的,所述的反射剂采用型号JH501水溶性纳米级 别无毒环保冰晶蓝颜料又称蓝色纳米颜料、JH101嫩叶绿色 颜料又称绿色纳米颜料,根据具体需要既可以单独使用也可 以复配使用,其作用是:当涂复到皮下有隐藏的静脉血管皮 肤表面时,加强血管对于蓝色光波的反射强度,与周围皮肤 之间形成更大的颜色反差,提高皮下静脉血管观察清晰度; 由于血管对绿光也有一定的反射作用,长波蓝光和短波绿光 反射光谱是衔接在一起的,当蓝色纳米颜料和绿色纳米颜料 混合使用时,可以加宽血管对蓝绿复合光色谱的反射光频带 宽度,进一步显示出静脉血管的特征,当蓝色纳米颜料、绿 色纳米颜料混合使用时,复配比例按蓝色纳米颜料2-3比绿 色纳米颜料1的重量比配制。Furthermore, the reflective agent adopts model JH501 water-soluble nano-level non-toxic and environmentally friendly ice crystal blue pigment, also known as blue nano pigment, and JH101 young leaf green pigment, also known as green nano pigment, which can be used alone or in combination according to specific needs. When used, its function is: when applied to the surface of the skin with hidden veins and blood vessels under the skin, the reflection intensity of the blood vessels for blue light waves is enhanced, forming a greater color contrast with the surrounding skin, and improving the clarity of observation of subcutaneous veins and blood vessels; Since blood vessels also reflect green light to a certain extent, the reflection spectra of long-wave blue light and short-wave green light are connected together. When blue nanopigments and green nanopigments are mixed, the reflection of blood vessels on the blue-green composite light spectrum can be broadened. The light frequency band width further shows the characteristics of veins. When blue nanopigments and green nanopigments are mixed, the compound ratio is based on the weight ratio of 2-3 blue nanopigments to 1 green nanopigments.

进一步的,所述的反射增强剂采用型号L6829水溶性无 毒环保蓝色纳米荧光颜料、L6828绿色纳米荧光颜料,根据 具体需要既可以单独使用也可以复配使用,其作用原理是纳 米荧光颜料在自然光照下会发出亮光,当与蓝色纳米颜料、 绿色纳米颜料单独或混合后涂复在隐藏静脉血管的皮肤表 面时,可以提高皮下静脉血管表面反射蓝光、绿光的反射光 强,起到增强观察清晰度的正向协同作用,提高观察效果; 当蓝色纳米荧光粉、绿色纳米荧光粉混合使用时,复配比例 按蓝色纳米荧光粉2-3比绿纳米荧光粉1的重量比配制,其 作用原理与上述蓝色纳米颜料、绿色纳米颜料混合复配使用 时增强观察效果的原理相同。Further, the reflection enhancer adopts models L6829 water-soluble non-toxic environmentally friendly blue nano-fluorescent pigment and L6828 green nano-fluorescent pigment. It can be used alone or in combination according to specific needs. The principle of action is that the nano-fluorescent pigment It will emit bright light under natural light. When applied alone or mixed with blue nanopigments and green nanopigments on the skin surface that hides veins and blood vessels, it can increase the reflected light intensity of blue and green light reflected from the surface of subcutaneous veins and blood vessels. Positive synergy to enhance observation clarity and improve observation effects; When blue nanophosphor powder and green nanophosphorus powder are mixed, the compounding ratio should be 2-3 of blue nanophosphor powder to 1 weight ratio of green nanophosphor powder The principle of action is the same as the principle of enhancing the observation effect when the above-mentioned blue nanopigment and green nanopigment are mixed and used.

进一步的,所述的渗透剂均采用水溶性渗透剂,如:72-6 系列渗透剂、噻酮、氮酮、月桂氮卓酮、二甲基亚砜皮肤渗 透剂和丙二醇促渗透剂,上述渗透剂可以根据具体需要单用 与复合使用,渗透剂在本产品中所起的作用原理是在皮肤表 面涂抹渗透剂后,通过使皮肤角质层的类脂质(约含15%)产 生不规则的排列,进而使细胞中脂类包层开裂,让光透明剂 通过角质层,提高皮肤表面的透明度,便于皮下静脉血管观 察和提高蓝光、绿光纳米颜料的反光率。Further, the said penetrants all adopt water-soluble penetrants, such as: 72-6 series penetrants, thiazone, azone, laurel azazone, dimethyl sulfoxide skin penetrant and propylene glycol penetration enhancer, as mentioned above The penetrating agent can be used alone or in combination according to specific needs. The principle of the penetrating agent in this product is to make the lipids (about 15%) in the stratum corneum of the skin irregularities after applying the penetrating agent on the skin surface. Arrangement, thereby cracking the lipid coating in the cells, allowing the light-transparent agent to pass through the stratum corneum, improving the transparency of the skin surface, making it easier to observe subcutaneous veins and blood vessels, and improving the reflectivity of blue-light and green-light nanopigments.

进一步的,所述的光透明剂采用水溶性聚乙二醇400、 丙三醇、葡萄糖,根据具体配制要求单独或复合使用,光透 明剂在本产品中所起的作用是;在渗透剂的帮助下渗入到皮 肤角质层下面,使皮肤变的透明,把被角质层挡住的静脉血 管曝露显示出来便于血管观察。Further, the optical transparency agent adopts water-soluble polyethylene glycol 400, glycerin, and glucose, which can be used alone or in combination according to specific preparation requirements. The role of the optical transparency agent in this product is: in the penetration of the penetrant It penetrates into the skin below the stratum corneum with help, making the skin transparent and exposing the veins and blood vessels blocked by the stratum corneum for easy observation of blood vessels.

进一步的,所述的非离子表面活性剂采用水溶性异丙醇 酰胺df21、十二烷基苯磺酸钠、聚氧乙烯醚系列的非离子型 表面活性剂,非离子表面活性剂在本消毒液中所起的作用 是:非离子表面活性剂本身具有亲水亲油两面活性,加入本 产品显影消毒液中可以起到协同促进渗透剂加强向皮肤角 质层内渗透的协同作用和促进颜料分子在消毒液中分布均 匀的分散特性。Further, the nonionic surfactant adopts water-soluble isopropanolamide df21, sodium dodecyl benzene sulfonate, and polyoxyethylene ether series nonionic surfactants. The nonionic surfactant is used in this disinfection. The function of the liquid is: the non-ionic surfactant itself has hydrophilic and lipophilic dual-sided activities. When added to the developing disinfectant of this product, it can synergistically promote the penetration of the penetrating agent into the stratum corneum of the skin and promote the pigment molecules. Dispersion properties for uniform distribution in disinfectant solutions.

进一步的,所述的蒸馏水采用常规蒸发过滤制取得的蒸 馏水,纯净程度要求符合国家相关标准。杂质含量不超过 0.01%。Further, the distilled water is obtained by conventional evaporation and filtration, and the purity is required to comply with relevant national standards. Impurity content does not exceed 0.01%.

进一步的,所述的消毒酒精采用符合国家消毒制剂要求 的工业级医用消毒酒精,酒精纯度99.98%,在本消毒液中 所起的作用是:使细菌的内部细胞脱水蛋白变性失去活性, 实现皮肤表面杀菌消毒。Furthermore, the disinfectant alcohol adopts industrial-grade medical disinfectant alcohol that meets the requirements of national disinfection preparations. The alcohol purity is 99.98%. Its function in this disinfectant is to denature and inactivate the dehydration protein of the internal cells of the bacteria, thereby achieving the goal of protecting the skin. Surface sterilization and disinfection.

光波反射血管显影皮肤表面消毒液的制作方法:Method for producing light wave reflection vascular imaging skin surface disinfectant:

步骤一:先制备母液;Step 1: Prepare the mother liquor first;

步骤二:将母液与医用酒精的进行融合,配制比例如下: 先按常规生产工艺流程配制出含水25%,含工业酒精75%的 75%医用消毒酒精1000毫升,在低速搅拌条件下缓慢加入显 影母液50-100毫升,搅拌均匀后装瓶备用。Step 2: Combine the mother liquor and medical alcohol. The preparation ratio is as follows: First, according to the conventional production process, prepare 1000 ml of 75% medical disinfectant alcohol containing 25% water and 75% industrial alcohol. Add the developer slowly under low-speed stirring conditions. 50-100 ml of mother liquor, stir well and bottle for later use.

制作显影母液配比实施例如下:Examples of the proportions of developing mother liquor are as follows:

实施例1:Example 1:

蒸馏水100毫升、反射剂蓝色染料0.01克、反射增强剂蓝色 萤光粉0.01克、渗透剂噻酮3-5克、光透明剂丙三醇10-20克、非 离子表面活性剂十二烷基苯磺酸钠1克,加入烧杯内,在电动搅 拌器上面中速搅拌5-10分钟,制得显影母液。100 ml of distilled water, 0.01 g of reflective blue dye, 0.01 g of reflective enhancer blue phosphor, 3-5 g of penetrant thione, 10-20 g of light-transparent agent glycerol, and 12 grams of non-ionic surfactant Add 1 gram of sodium alkyl benzene sulfonate into the beaker and stir on an electric mixer at medium speed for 5-10 minutes to prepare a developing mother liquor.

实施例2:Example 2:

蒸馏水100毫升、反射剂蓝色染料0.01克、反射增强剂蓝色 萤光粉0.01克、渗透剂72-6型5克、光透明剂葡萄糖10克、非离 子表面活性剂聚氧乙烯醚1克、防腐剂山梨酸钾0.1克,加入烧 杯内,在电动搅拌器上面中速搅拌5-10分钟,制得显影母液。100 ml of distilled water, 0.01 g of reflective blue dye, 0.01 g of reflection enhancer blue phosphor, 5 g of penetrating agent 72-6, 10 g of light transparency agent glucose, 1 g of nonionic surfactant polyoxyethylene ether , 0.1 g of preservative potassium sorbate, add it to the beaker, and stir on an electric mixer at medium speed for 5-10 minutes to prepare a developing mother liquor.

实施例3:Example 3:

蒸馏水100毫升、反射剂蓝、绿色染料各0.01克、反射增强 剂蓝、绿色萤光粉各0.01克、渗透剂月桂氮卓酮10克、光透明 剂丙三醇10-20克、非离子表面活性剂十二烷基苯磺酸钠1克, 加入烧杯内,在电动搅拌器上面中速搅拌5-10分钟,制得显影 母液。100 ml of distilled water, 0.01 g each of blue and green dyes as reflectants, 0.01 g each of blue and green phosphors as reflection enhancers, 10 g of penetrant azazone, 10-20 g of light-transparent agent glycerol, non-ionic surface Add 1 gram of the active agent sodium dodecylbenzene sulfonate into the beaker and stir on an electric mixer at medium speed for 5-10 minutes to prepare a developing mother liquor.

蒸馏水100毫升、反射剂绿色染料0.01克、反射增强剂绿色 萤光粉0.01克、渗透剂氮酮10克、光透明剂聚乙二醇40020克、 非离子表面活性剂异丙醇酰胺df21/2克、加入烧杯内,在电动 搅拌器上面中速搅拌5-10分钟,制得显影母液。100 ml of distilled water, 0.01 g of reflective agent green dye, 0.01 g of reflection enhancer green fluorescent powder, 10 g of penetrating agent azone, 40020 g of optical transparency agent polyethylene glycol, non-ionic surfactant isopropyl amide df21/2 g. Add it to the beaker and stir on an electric mixer at medium speed for 5-10 minutes to prepare the developing mother liquor.

实施例4:Example 4:

蒸馏水100毫升、反射剂蓝、绿色染料各0.01克、反射增强 剂蓝、绿色萤光粉各0.01克、渗透剂月桂氮卓酮10克、光透明 剂丙三醇10-20克、非离子表面活性剂十二烷基苯磺酸钠1克, 加入烧杯内,在电动搅拌器上面中速搅拌5-10分钟,制得显影 母液。100 ml of distilled water, 0.01 g each of blue and green dyes as reflectants, 0.01 g each of blue and green phosphors as reflection enhancers, 10 g of penetrant azazone, 10-20 g of light-transparent agent glycerol, non-ionic surface Add 1 gram of the active agent sodium dodecylbenzene sulfonate into the beaker and stir on an electric mixer at medium speed for 5-10 minutes to prepare a developing mother liquor.

参照图1图2,图1照片是涂抹75%常规医用酒精消毒液后的 右手背,图2照片是涂抹血管显影皮肤表面消毒液后的同一手 背,通过对比可以看出涂抹血管显影皮肤消毒液与涂抹常规医 用酒精消毒液的明显差别,取得了明显的血管显影效果。Refer to Figure 1 and Figure 2. The photo in Figure 1 is the back of the right hand after applying 75% conventional medical alcohol disinfectant. The photo in Figure 2 is the back of the same hand after applying the vascular developing skin surface disinfectant. By comparison, it can be seen that the vascular developing skin surface disinfectant is applied. It is significantly different from applying conventional medical alcohol disinfectant and achieves obvious blood vessel development effect.

参照图3图4,图3照片是涂抹75%常规医用酒精消毒液后的 右脚背,图4照片是涂抹血管显影皮肤表面消毒液后的同一脚 背,通过对比可以看出涂抹血管显影皮肤消毒液与涂抹常规医 用酒精消毒液的明显差别,取得了明显的血管显影效果。Refer to Figure 3 and Figure 4. The photo in Figure 3 is the instep of the right foot after applying 75% conventional medical alcohol disinfectant. The photo in Figure 4 is the same instep after applying the disinfectant on the surface of the vascular developing skin. By comparison, it can be seen that the instep is applied on the surface of the vascular developing skin disinfectant. It is significantly different from applying conventional medical alcohol disinfectant and achieves obvious blood vessel development effect.

消毒液具体使用操作过程:本发明产品一种光波反射血管 显影皮肤表面消毒液的使用方法如下:打吊瓶前,医护人员先 按常规操方法用橡皮筋扎紧手腕,停止静脉血管内的血液流 动,然后拍打准备扎针的手背表面,激发血管隆起,最后用医 用消毒棉签蘸取本消毒液擦拭需要扎针的部位,此时,消毒部 位皮下隐藏的静脉血管在本药液的联合作用下逐渐变的清晰, 使医护人员能够准确找到血管顺利下针,下针处理完毕,松开 橡皮筋,操作结束。The specific operation process of using the disinfectant: The method of using the product of the present invention, a light wave reflection blood vessel developing skin surface disinfectant, is as follows: before applying the hanging bottle, the medical staff should first use a rubber band to tighten the wrist according to conventional methods to stop the blood flow in the veins. flow, then tap the surface of the back of the hand where the needle is to be inserted to stimulate the blood vessels to swell, and finally use a medical sterilized cotton swab dipped in the disinfectant solution to wipe the area where the needle needs to be inserted. At this time, the venous blood vessels hidden under the skin of the disinfected site will gradually change under the combined action of this medicinal solution. The clarity allows the medical staff to accurately find the blood vessel and insert the needle smoothly. After the needle insertion is completed, the rubber band is loosened and the operation is completed.

以上结合具体实施方式和范例性实例对本发明进行了详细 说明,不过这些说明并不能理解为对本发明的限制。本领域技 术人员理解,在不偏离本发明精神和范围的情况下,可以对本 发明技术方案及其实施方式进行多种等价替换、修饰或改进, 这些均落入本发明的范围内。本发明的保护范围以所附权利要 求为准。The present invention has been described in detail above in conjunction with specific embodiments and exemplary examples, but these descriptions should not be construed as limitations of the present invention. Those skilled in the art understand that, without departing from the spirit and scope of the present invention, various equivalent substitutions, modifications or improvements can be made to the technical solutions and implementations of the present invention, which all fall within the scope of the present invention. The scope of protection of the present invention is determined by the appended claims.

Claims (9)

1.一种光波反射血管显影皮肤表面消毒液的制作方法,其特征在于,消毒液由母液、消毒酒精和蒸馏水三者按一定的比例配合而成。1. A method for producing a light wave reflection blood vessel developing skin surface disinfectant, which is characterized in that the disinfectant is composed of mother liquor, disinfectant alcohol and distilled water in a certain proportion. 2.根据权利要求1所述的一种光波反射血管显影皮肤表面消毒液的制作方法,其特征在于,所述母液由蒸馏水、反射剂、反射增强剂、渗透剂、光透明剂、非离子表面活性剂所组成。2. A method for making a light wave reflection blood vessel developing skin surface disinfectant according to claim 1, characterized in that the mother liquor is composed of distilled water, a reflective agent, a reflection enhancer, a penetrating agent, a light-transparent agent, and a non-ionic surface disinfectant. Composed of active agents. 3.根据权利要求2所述的一种光波反射血管显影皮肤表面消毒液的制作方法,其特征在于,所述反射剂采用型号JH501水溶性纳米级别无毒环保冰晶蓝颜料和/或JH101嫩叶绿色颜料。3. A method for making a light wave reflection blood vessel developing skin surface disinfectant according to claim 2, characterized in that the reflective agent adopts model JH501 water-soluble nano-level non-toxic environmentally friendly ice crystal blue pigment and/or JH101 young leaves. green pigment. 4.根据权利要求2所述的一种光波反射血管显影皮肤表面消毒液的制作方法,其特征在于,所述反射增强剂采用型号L6829水溶性无毒环保蓝色纳米荧光颜料和/或L6828绿色纳米荧光颜料。4. A method for making a light wave reflection blood vessel developing skin surface disinfectant according to claim 2, characterized in that the reflection enhancer adopts model L6829 water-soluble non-toxic environmentally friendly blue nano-fluorescent pigment and/or L6828 green Nano fluorescent pigments. 5.根据权利要求2所述的一种光波反射血管显影皮肤表面消毒液的制作方法,其特征在于,所述渗透剂采用水溶性渗透剂。5. A method for producing a light wave reflection blood vessel developing skin surface disinfectant according to claim 2, characterized in that the penetrant is a water-soluble penetrant. 6.根据权利要求2所述的一种光波反射血管显影皮肤表面消毒液的制作方法,其特征在于,所述光透明剂采用水溶性聚乙二醇400和/或丙三醇和/或葡萄糖。6. A method for making a light wave reflection blood vessel developing skin surface disinfectant according to claim 2, characterized in that the light transparency agent uses water-soluble polyethylene glycol 400 and/or glycerin and/or glucose. 7.根据权利要求2所述的一种光波反射血管显影皮肤表面消毒液的制作方法,其特征在于,所述非离子表面活性剂采用水溶性异丙醇酰胺df21和/或十二烷基苯磺酸钠和/或聚氧乙烯醚系列的非离子型表面活性剂。7. A method for making a light wave reflection blood vessel developing skin surface disinfectant according to claim 2, characterized in that the nonionic surfactant adopts water-soluble isopropanolamide df21 and/or dodecylbenzene Sodium sulfonate and/or polyoxyethylene ether series nonionic surfactants. 8.根据权利要求2所述的一种光波反射血管显影皮肤表面消毒液的制作方法,其特征在于,所述蒸馏水采用常规蒸发过滤制取得的蒸馏水,纯净程度要求符合国家相关标准,杂质含量不超过0.01%。8. A method for making a light wave reflection blood vessel developing skin surface disinfectant according to claim 2, characterized in that the distilled water is obtained by conventional evaporation and filtration, and the degree of purity is required to comply with relevant national standards, and the impurity content is not More than 0.01%. 9.根据权利要求2所述的一种光波反射血管显影皮肤表面消毒液的制作方法,其特征在于,所述消毒酒精采用符合国家消毒制剂要求的工业级医用消毒酒精,酒精纯度99.98%。9. A method for making a light wave reflection blood vessel developing skin surface disinfectant according to claim 2, characterized in that the disinfectant alcohol adopts industrial grade medical disinfectant alcohol that meets the national disinfection preparation requirements, and the alcohol purity is 99.98%.
CN202111483326.0A 2021-12-07 2021-12-07 A method for producing a light wave reflection blood vessel developing skin surface disinfectant Pending CN116808007A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111483326.0A CN116808007A (en) 2021-12-07 2021-12-07 A method for producing a light wave reflection blood vessel developing skin surface disinfectant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111483326.0A CN116808007A (en) 2021-12-07 2021-12-07 A method for producing a light wave reflection blood vessel developing skin surface disinfectant

Publications (1)

Publication Number Publication Date
CN116808007A true CN116808007A (en) 2023-09-29

Family

ID=88120766

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111483326.0A Pending CN116808007A (en) 2021-12-07 2021-12-07 A method for producing a light wave reflection blood vessel developing skin surface disinfectant

Country Status (1)

Country Link
CN (1) CN116808007A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4015591A (en) * 1976-02-17 1977-04-05 Liquid Crystal Products, Inc. Cholesteric liquid crystalline phase material-dye composition and venapuncture method employing the composition
WO2005051365A1 (en) * 2003-11-27 2005-06-09 Medis S.R.L. Composition and device for facilitating venipuncture
US20080071247A1 (en) * 2006-09-18 2008-03-20 Dimera Incorporated Topical administration of a salt compound to facilitate venipuncture
US20110202003A1 (en) * 2010-02-18 2011-08-18 Cook Harold D Method of locating vessel puncture access sites via tattoo or permanent marking
US20150044301A1 (en) * 2013-08-08 2015-02-12 Hans Werner Bottesch System for improving safety and efficacy in the preparation of an injection site
CN105561347A (en) * 2015-12-31 2016-05-11 上海宇昂新材料科技有限公司 Angiography enhancer

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4015591A (en) * 1976-02-17 1977-04-05 Liquid Crystal Products, Inc. Cholesteric liquid crystalline phase material-dye composition and venapuncture method employing the composition
WO2005051365A1 (en) * 2003-11-27 2005-06-09 Medis S.R.L. Composition and device for facilitating venipuncture
US20080071247A1 (en) * 2006-09-18 2008-03-20 Dimera Incorporated Topical administration of a salt compound to facilitate venipuncture
US20110202003A1 (en) * 2010-02-18 2011-08-18 Cook Harold D Method of locating vessel puncture access sites via tattoo or permanent marking
US20150044301A1 (en) * 2013-08-08 2015-02-12 Hans Werner Bottesch System for improving safety and efficacy in the preparation of an injection site
CN105561347A (en) * 2015-12-31 2016-05-11 上海宇昂新材料科技有限公司 Angiography enhancer

Similar Documents

Publication Publication Date Title
Crocker Diseases of the Skin: Their Description, Pathology, Diagnosis, and Treatment, with Special Reference to the Skin Eruptions of Children and an Analysis of Twelve Thousand Cases of Skin Disease
Crocker Diseases of the skin: their description, pathology, diagnosis, and treatment
CN104094923B (en) A kind of antiseptic preserving fluid for corpse, tissue and dissection and using method thereof
EA029534B1 (en) COMBINATION OF OXIDANT AND PHOTOACTIVATOR FOR THE HEALING OF RAS
Sequeira Diseases of the Skin
CN106714843A (en) Biophotonic compositions comprising halogen and uses thereof
TW200822860A (en) Embalming mixture, preparation method therefor, and method of treating corpses with the embalming mixture
CN116808007A (en) A method for producing a light wave reflection blood vessel developing skin surface disinfectant
EP2257179A1 (en) Composition for tissue preservation
CN110201190A (en) A kind of coloring agent and preparation method thereof for cancer of the esophagus early diagnosis
CN102309505A (en) Application of drug composition in preparation of drugs for treating organic sexual dysfunction
CN114146033A (en) Traditional Chinese medicine hand sanitizer and preparation method thereof
CN102028706B (en) Flushing liquid for liver-cancer surgical incisions
CN106580771A (en) Children's toothpaste
Yap et al. Patent blue dye in lymphaticovenular anastomosis
Abdulkareem et al. The efficacy of ozonated saline solution against protoscoleces of cystic echinococcosis in liver hydatid surgery
Crocker Diseases of the skin: their description, pathology, diagnosis, and treatment: with special reference to the skin eruptions of children
CN108635312A (en) A kind of plant essence scar rehabilitating solution and preparation method thereof
CN116271108B (en) A kind of digestive tract mucosal dye and preparation method thereof
RU2802551C1 (en) Method of treatment of erosive and ulcerent form of lichen flat of mouth mucosa
Adams et al. Surgery, with Special Reference to Podiatry
RU2384341C1 (en) Pharmaceutical composition for psoriasis treatment
Newcomer et al. Unique wounds and wound emergencies
CN109045057A (en) Application of the astilbin in preparation treatment neurotrosis drug
Al-Hasnawi et al. Evaluation Activity of Boiled Aqueous Extract of Broccoli Flower Plant (Brassica Oleraceae L. Var. Italic) And Albendazole Drug Against the Protoscolices in Vitro

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Country or region after: China

Address after: 276000 Room 406, Building A, Linyi Science and Technology Entrepreneurship Park, High tech Zone, Linyi City, Shandong Province

Applicant after: Kaixing Intelligent Technology (Linyi) Co.,Ltd.

Address before: 276000 room 509, block a, Linyi science and technology entrepreneurship Park, high tech Zone, Linyi City, Shandong Province

Applicant before: Linyi Kaixing Medical Technology Co.,Ltd.

Country or region before: China

CB02 Change of applicant information
RJ01 Rejection of invention patent application after publication

Application publication date: 20230929

RJ01 Rejection of invention patent application after publication